FDA vaccine panel supports COVID shots for young children
In a major step, a Food and Drug Administration panel has recommended authorizing Moderna's two-dose COVID-19 vaccine for children under the age of 6, and Pfizer's three-dose vaccine for children under the age of 5. CBS News correspondent Meg Oliver reports, and then Denis Nash, professor of epidemiology from the CUNY Graduate School of Public Health, discusses the latest developments.